CD86 regulates myeloma cell survival

Although prognosis for patients with multiple myeloma has improved over the past decade, research toward discovery of new therapeutic avenues is important and could lead to a cure for this plasma cell malignancy. Here we show that blocking the CD28-CD86 pathway via silencing of either CD28 or CD86 l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Gavile, Catherine M., Barwick, Benjamin G., Newman, Scott, Neri, Paola, Nooka, Ajay K., Lonial, Sagar, Lee, Kelvin P., Boise, Lawrence H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729629/
https://ncbi.nlm.nih.gov/pubmed/29296880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017011601
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados